ATE394095T1 - Stabile desmopressinformulierung in fester form - Google Patents

Stabile desmopressinformulierung in fester form

Info

Publication number
ATE394095T1
ATE394095T1 AT06005326T AT06005326T ATE394095T1 AT E394095 T1 ATE394095 T1 AT E394095T1 AT 06005326 T AT06005326 T AT 06005326T AT 06005326 T AT06005326 T AT 06005326T AT E394095 T1 ATE394095 T1 AT E394095T1
Authority
AT
Austria
Prior art keywords
stable
solid form
desmopressin formulation
desmopressin
formulation
Prior art date
Application number
AT06005326T
Other languages
English (en)
Inventor
Christina Ulrika Jonius Aston
Lars-Erik Olsson
Lars Anders Ragnar Nilsson
Original Assignee
Ferring Int Ct Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36218059&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE394095(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Int Ct Sa filed Critical Ferring Int Ct Sa
Application granted granted Critical
Publication of ATE394095T1 publication Critical patent/ATE394095T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT06005326T 2006-03-02 2006-03-15 Stabile desmopressinformulierung in fester form ATE394095T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0600482A SE528446C2 (sv) 2006-03-02 2006-03-02 Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse

Publications (1)

Publication Number Publication Date
ATE394095T1 true ATE394095T1 (de) 2008-05-15

Family

ID=36218059

Family Applications (3)

Application Number Title Priority Date Filing Date
AT06005326T ATE394095T1 (de) 2006-03-02 2006-03-15 Stabile desmopressinformulierung in fester form
AT0020406U AT8372U3 (de) 2006-03-02 2006-03-16 Desmopressin umfassende zusammensetzung
AT0043906A AT503320A1 (de) 2006-03-02 2006-03-16 Desmopressin umfassende zusammensetzung

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT0020406U AT8372U3 (de) 2006-03-02 2006-03-16 Desmopressin umfassende zusammensetzung
AT0043906A AT503320A1 (de) 2006-03-02 2006-03-16 Desmopressin umfassende zusammensetzung

Country Status (16)

Country Link
US (1) US20100273709A1 (de)
EP (1) EP1829532B1 (de)
JP (1) JP4976428B2 (de)
AT (3) ATE394095T1 (de)
CY (1) CY1108231T1 (de)
DE (2) DE602006001103D1 (de)
DK (1) DK1829532T3 (de)
ES (1) ES2304033T3 (de)
IL (1) IL193250A0 (de)
NL (1) NL1031397C2 (de)
NO (1) NO20083555L (de)
PL (1) PL1829532T3 (de)
PT (1) PT1829532E (de)
RU (1) RU2340351C1 (de)
SE (1) SE528446C2 (de)
SI (1) SI1829532T1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
CN103304639A (zh) * 2013-06-08 2013-09-18 深圳翰宇药业股份有限公司 一种纯化去氨加压素中间体的方法
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) * 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
US7074871B2 (en) * 1992-05-29 2006-07-11 Basell Poliolefine Italia S.R.L. Crystalline polymers of propylene having improved processability in the molten state and process for their preparation
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
HU221617B1 (hu) * 1993-06-29 2002-12-28 Ferring B.V. Vizes készítmény dezmopresszin nazális adagolására
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5985835A (en) * 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
WO1995001368A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Improved synthesis of cyclic peptides
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) * 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
AR014640A1 (es) * 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
GB2355454A (en) * 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US6348486B1 (en) * 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
US6509040B1 (en) * 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US6667277B2 (en) * 2001-08-24 2003-12-23 National Starch And Chemical Investment Holding Corporation Water dispersible starch based physical form modification of agricultural agents
WO2003094886A2 (en) * 2002-05-07 2003-11-20 Ferring Bv Desmopressin in an orodispersible dosage form
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
US7022340B2 (en) * 2003-07-25 2006-04-04 Ferring B.V. Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP2322195A2 (de) * 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
US7344725B2 (en) * 2003-11-25 2008-03-18 Alcon, Inc. Use of inorganic nanoparticles to stabilize hydrogen peroxide solutions
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
SI1550439T1 (sl) * 2003-12-29 2006-08-31 Ferring Bv Postopek za pripravo trdne dozirne oblike dezmopresina
BRPI0610046A2 (pt) * 2005-04-22 2010-05-25 Wyeth Corp derivados de benzodioxano e benzodioxolano e usos destes

Also Published As

Publication number Publication date
CY1108231T1 (el) 2014-02-12
NO20083555L (no) 2008-08-18
US20100273709A1 (en) 2010-10-28
AT503320A1 (de) 2007-09-15
PL1829532T3 (pl) 2008-09-30
JP2009528312A (ja) 2009-08-06
DE602006001103D1 (de) 2008-06-19
EP1829532A1 (de) 2007-09-05
SE0600482L (sv) 2006-11-14
DK1829532T3 (da) 2008-08-04
EP1829532B1 (de) 2008-05-07
IL193250A0 (en) 2011-08-01
ES2304033T3 (es) 2008-09-01
RU2007107368A (ru) 2008-09-10
SI1829532T1 (sl) 2008-08-31
DE202006004746U1 (de) 2006-06-29
NL1031397C2 (nl) 2006-09-18
AT8372U3 (de) 2007-03-15
RU2340351C1 (ru) 2008-12-10
AT8372U2 (de) 2006-07-15
JP4976428B2 (ja) 2012-07-18
PT1829532E (pt) 2009-02-13
NL1031397A1 (nl) 2006-05-08
SE528446C2 (sv) 2006-11-14

Similar Documents

Publication Publication Date Title
DK3120701T3 (da) Stabile sulfoximin-insekticide sammensætninger
DK2349430T3 (da) KATETERISERINGANORDNING og -kit
BRPI0913086A2 (pt) Composições antimicrobianas e métodos de uso
BRPI0821077A2 (pt) Formulação em gel
BRPI0919552A2 (pt) Formulações de glifosato contendo surfactantes e amidoalquilamina
DK2068886T3 (da) Lipidholdige præparater
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
ATE394095T1 (de) Stabile desmopressinformulierung in fester form
BRPI0716300A2 (pt) Artigo e mistura
BRPI0907365A2 (pt) Composição antimicrobiana e uso
BRPI0908596A2 (pt) formulação e composição farmacêutica de liberação prolongada
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
BRPI0822221A2 (pt) Composições aquosas e estáveis de ciclosporina
BRPI0814188A2 (pt) Formulações
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
ATE522136T1 (de) Wirkstoffsuspensionen in glycerin
DK1978944T3 (da) Blød-gelatine-kapselformulering
DE602009000788D1 (de) Positive Resistzusammensetzungen und Strukturierungsverfahren
DE602007001341D1 (de) Niederhaltevorrichtung in einer endappliziereinrichtung
DE602007007755D1 (de) Fußplatte
DK2097469T3 (da) Stabile laktidpartikler
FR2896414B1 (fr) Composition cosmetique matifiante
BRPI0918579A2 (pt) composição de gel tensoativa
EE200800057A (et) Antimikroobne ravimvorm
BRPI0716802A2 (pt) Expressão de tgf-beta em plastídeos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1829532

Country of ref document: EP